Detection Kit for Group A Rotavirus and Adenovirus antigens (Colloidal gold) – Macro & Micro-Test

Short Description:

Product Detail

Product Tags

Feedback (2)

With this motto in mind, we've come to be one of quite possibly the most technologically innovative, cost-efficient, and price-competitive manufacturers for Braf Mutation Thyroid Cancer, Braf Mutation Lung Cancer, Human Egfr Gene 29 Mutations Detection Kit (Fluorescence Pcr）, Created products with brand value. We attend seriously to produce and behave with integrity, and by the favor of customers at home and abroad in the xxx industry.

Detection Kit for Group A Rotavirus and Adenovirus antigens (Colloidal gold) – Macro & Micro-Test Detail:

Product name

Detection Kit for Group A Rotavirus and Adenovirus antigens (Colloidal gold)

Certificate

Epidemiology

Rotavirus (Rv) is an important pathogen causing viral diarrhea and enteritis in infants worldwide^[1], belonging to the reovirus family, is a double-stranded RNA virus. Group A rotavirus is the main pathogen causing severe diarrhea in infants and young children^[2]. Rotavirus with the virus excreted feces, through the fecal route infected patients^[3], the proliferation of cells in the duodenal mucosa of the children affected the normal absorption of salts, sugars and water in the intestines of the children, resulting in diarrhea^[4].

Adenovirus (Adv) belongs to the Adenovirus family. Type 40 and 41 of Group F can induce diarrhea in infants. They are the second most important pathogen in viral diarrhea in children, next to rotavirus. The main transmission route of adenovirus is fecal-oral transmission, the incubation period of infection is about 10 days, and the main symptoms are diarrhea, accompanied by vomiting and fever^[5].

Features

● Rapid: Read results within 10 minutes
● Easy to use: Only 3 steps
● Convenient: No instrument
● Room temperature: Transportation & storage at 2-30℃ for 12 months
● Accuracy: High sensitivity & specificity

Technical Parameters

Target region	Group A rotavirus and adenovirus
Storage temperature	2℃-30℃
Sample type	Stool samples
Shelf life	12 months
Auxiliary instruments	Not required
Extra Consumables	Not required
Detection time	10-15 mins
Specificity	detection of bacteria by kit include: group B streptococcus, haemophilus influenzae, group C streptococcus, candida albicans, pseudomonas aeruginosa, klebsiella pneumoniae, staphylococcus aureus, enterococcus faecium, enterococcus faecalis, neisseria meningococcus, neisseria gonorrhoeae, acinetobacter , proteus mirabilis, acinetobacter calcium acetate, escherichia coli, proteus vulgaris, gardnerella vaginalis, salmonella, shigella, chlamydia trachomatis, helicobacter pylori, there is no cross reaction

Work Flow

英语-A 群轮状病毒、腺病毒抗原

● Read the results (10-15 mins)

英语-A 群轮状病毒、腺病毒抗原

Precautions:
1. Do not read the result after 15 mins.
2. After opening, please use the product within half an hour.
3. Please add samples in strict accordance with the instructions.
4. Please perform the test according to the instructions to avoid collecting excessive stool samples or too viscous stool samples, which will cause the diluted sample to block the test cassette.

Main Components

Catalogue Number	Kit specifications	Composition	Component specifications	The number of
HWTS-EV016A	50 tests/kit	1. detection reagent card	1 piece/package	50 packages
HWTS-EV016A	50 tests/kit	2. Sample dilution	1 mL/piece	50 pieces
HWTS-EV016B	10 tests/kit	1. detection reagent card	1 piece/ package	10 packages
HWTS-EV016B	10 tests/kit	2. Sample dilution	1 mL/piece	10 pieces

Reference

[1] Zhang Chunfang, Jia Liying. Epidemiology of rotavirus infection in Asia [J]. Chinese Journal of Contemporary Pediatrics, 2006,89(1): 79-82.
[2] Li Manyuan. Value of rapid detection of rotavirus Group A antigen in clinical diagnosis and treatment of infant diarrhea. Chinese journal of minkang medicine, 2011,23 (14): 1747.
[3] Xu Xiaoling. Analysis of rotavirus antigen in feces of children with diarrhea and its clinical significance. Chinese journal of medical research, 2006,6 (12): 1404-1405.
[4] Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis[J]. N Engel J Med, 2006,354(1): 11-22.
[5] SCHMITZ, H. et al. Worldwide epidemiology in human Rotavirus infections, J. Epidemiology, 117:455-466.